Patents by Inventor Debasish Boral

Debasish Boral has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PSEUDOTYPED VIRAL PARTICLES, COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF
    Publication number: 20250171746
    Abstract: Provided for herein are mutant VSV-G polypeptides, compositions comprising the same, and methods of using the same. Also provided for herein are polypeptides and compositions that bind to CD7 and uses thereof. Also provided for herein are polypeptides and compositions that bind to CD8 and uses thereof.
    Type: Application
    Filed: January 31, 2025
    Publication date: May 29, 2025
    Inventors: Ronnie M. Russell, Philip R. Johnson, James I. Andorko, Mohit Sachdeva, Bruce Schnepp, Michael Marinelli, Jeffrey Foss, Debasish Boral
  • PSEUDOTYPED VIRAL PARTICLES, COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF
    Publication number: 20240287472
    Abstract: Provided for herein are mutant VSV-G polypeptides, compositions comprising the same, and methods of using the same. Also provided for herein are polypeptides and compositions that bind to CD7 and uses thereof. Also provided for herein are polypeptides and compositions that bind to CD8 and uses thereof.
    Type: Application
    Filed: April 26, 2024
    Publication date: August 29, 2024
    Inventors: Ronnie M. Russell, Philip R. Johnson, James I. Andorko, Mohit Sachdeva, Bruce Schnepp, Michael Marinelli, Jeffrey Foss, Debasish Boral
  • FUSOGENIC RHABDOVIRUS GLYCOPROTEINS AND USES THEREOF
    Publication number: 20230293688
    Abstract: Provided for herein are fusogenic rhabdovirus glycoproteins and uses thereof, compositions comprising the same, and methods of using the same. Also provided for herein are pseudotyped viral particles comprising rhabdovirus glycoproteins as provided for herein and targeting moieties as provided for herein. Also provided are methods of generating and using the pseudotyped viral particles as provided for herein.
    Type: Application
    Filed: February 10, 2023
    Publication date: September 21, 2023
    Inventors: Ronnie M. Russell, Bruce Schnepp, James I. Andorko, Michael Marinelli, Mohit Sachdeva, Debasish Boral, Jeffery Foss
  • PSEUDOTYPED VIRAL PARTICLES, COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF
    Publication number: 20230295332
    Abstract: Provided for herein are mutant VSV-G polypeptides, compositions comprising the same, and methods of using the same. Also provided for herein are polypeptides and compositions that bind to CD7 and uses thereof. Also provided for herein are polypeptides and compositions that bind to CD8 and uses thereof.
    Type: Application
    Filed: December 15, 2022
    Publication date: September 21, 2023
    Inventors: Ronnie M. Russell, Philip R. Johnson, James I. Andorko, Mohit Sachdeva, Bruce Schnepp, Michael Marinelli, Jeffrey Foss, Debasish Boral
  • PSEUDOTYPED VIRAL PARTICLES, COMPOSITIONS COMPRISNG THE SAME, AND USES THEREOF
    Publication number: 20230279363
    Abstract: Provided for herein are mutant VSV-G polypeptides, compositions comprising the same, and methods of using the same. Also provided for herein are polypeptides and compositions that bind to CD7 and uses thereof. Also provided for herein are polypeptides and compositions that bind to CD8 and uses thereof.
    Type: Application
    Filed: January 20, 2023
    Publication date: September 7, 2023
    Inventors: Ronnie M. Russell, Philip R. Johnson, James I. Andorko, Mohit Sachdeva, Bruce Schnepp, Michael Marinelli, Jeffrey Foss, Debasish Boral